Literature DB >> 24276113

Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.

Marzia Pasquali1, Elisabeth Schwarz, Maren Jensen, Tatiana Yuzyuk, Irene DeBiase, Harper Randall, Nicola Longo.   

Abstract

Guanidinoacetate methyltransferase (GAMT) deficiency causes brain creatine deficiency characterized by developmental delays, speech delay, seizures and autism-like behavior. Identification and therapy at birth because of a positive family history has prevented intellectual disability and seizures in all cases reported. The objective of this study was to develop a method to identify patients with GAMT deficiency from newborn screening blood spots. Creatine and guanidinoacetate were extracted from 10,000 deidentified blood spots using the same protocol routinely used for newborn screening and quantified by stable isotope dilution using deuterated creatine and guanidinoacetate as internal standards. Residual dried blood spots from three infants with GAMT deficiency were used to evaluate the sensitivity of the method. A second tier test using UPLC-MS/MS was performed to analyze samples with a concentration of guanidinoacetate >2.44 μmol/L (99.5th centile of the normal population). Fifty four blood spots required second tier testing in addition to seven blood spots from three patients with GAMT deficiency retrospectively analyzed. With second tier testing, only the samples from GAMT deficiency patients had elevated concentration of guanidinoacetate. Our results show that GAMT deficiency can be identified in newborns using routine extraction methods. The cost of this additional screening is minimal, as it does not require additional instrumentation, procedure, or sample collection. The use of a second tier test can reduce the false positive rate to a minimum. Summary Brain creatine deficiency syndromes cause mental retardation that can be prevented if therapy is initiated early in life. This manuscript reports that infants with GAMT deficiency (one of the brain creatine deficiency syndromes) can be identified from elevated guanidinoacetate in newborn blood spots with virtually absent false-positive results using a second tier test.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24276113     DOI: 10.1007/s10545-013-9662-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  18 in total

1.  Newborn screening: toward a uniform screening panel and system--executive summary.

Authors: 
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

2.  Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.

Authors:  A Schulze; G F Hoffmann; P Bachert; S Kirsch; G S Salomons; N M Verhoeven; E Mayatepek
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

3.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.

Authors:  G S Salomons; S J van Dooren; N M Verhoeven; K M Cecil; W S Ball; T J Degrauw; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

4.  Low creatinine: the diagnostic clue for a treatable neurologic disorder.

Authors:  O A Bodamer; F Iqbal; A Mühl; C Hung; D Prayer; R Ratschmann; B C Item
Journal:  Neurology       Date:  2009-03-03       Impact factor: 9.910

5.  Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans.

Authors:  C B Item; S Stöckler-Ipsiroglu; C Stromberger; A Mühl; M G Alessandrì; M C Bianchi; M Tosetti; F Fornai; G Cioni
Journal:  Am J Hum Genet       Date:  2001-09-10       Impact factor: 11.025

Review 6.  Creatine deficiency syndromes.

Authors:  Andreas Schulze
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

7.  Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.

Authors:  Krista S Viau; Sharon L Ernst; Marzia Pasquali; Lorenzo D Botto; Gary Hedlund; Nicola Longo
Journal:  Mol Genet Metab       Date:  2013-09-08       Impact factor: 4.797

8.  Guanidinoacetate methyltransferase deficiency: first steps to newborn screening for a treatable neurometabolic disease.

Authors:  S Mercimek-Mahmutoglu; G Sinclair; S J M van Dooren; W Kanhai; P Ashcraft; O J Michel; J Nelson; O T Betsalel; L Sweetman; C Jakobs; G S Salomons
Journal:  Mol Genet Metab       Date:  2012-08-03       Impact factor: 4.797

Review 9.  Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism.

Authors:  C Stromberger; O A Bodamer; S Stöckler-Ipsiroglu
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency.

Authors:  J Vodopiutz; C B Item; M Häusler; H Korall; O A Bodamer
Journal:  J Child Neurol       Date:  2007-06       Impact factor: 1.987

View more
  5 in total

1.  Guanidinoacetate Methyltransferase Activity in Lymphocytes, for a Fast Diagnosis.

Authors:  Lisette M Berends; Eduard A Struys; Birthe Roos; Ulbe Holwerda; Erwin E W Jansen; Gajja S Salomons; Mirjam M C Wamelink
Journal:  JIMD Rep       Date:  2017-02-21

2.  Non-derivatized Assay for the Simultaneous Detection of Amino Acids, Acylcarnitines, Succinylacetone, Creatine, and Guanidinoacetic Acid in Dried Blood Spots by Tandem Mass Spectrometry.

Authors:  Carter K Asef; Kameron M Khaksarfard; Víctor R De Jesús
Journal:  Int J Neonatal Screen       Date:  2016-11-24

3.  Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  J Daniel Sharer; Olaf Bodamer; Nicola Longo; Silvia Tortorelli; Mirjam M C Wamelink; Sarah Young
Journal:  Genet Med       Date:  2017-01-05       Impact factor: 8.822

4.  Case Series of Creatine Deficiency Syndrome due to Guanidinoacetate Methyltransferase Deficiency.

Authors:  Vinu Narayan; Sunita Bijarnia Mahay; Ishwar Chander Verma; Ratna Dua Puri
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383

Review 5.  Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics.

Authors:  Israa T Ismail; Megan R Showalter; Oliver Fiehn
Journal:  Metabolites       Date:  2019-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.